Clinical OMICS

NOV-DEC 2017

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link:

Contents of this Issue


Page 45 of 47

44 Clinical OMICs November/December 2017 Industry Events robuart / Getty Images ASH Annual Meeting Atlanta, December 9–12 The American Society of Hematology Annual Meeting is the world's premier event in malignant and nonmalignant hematology. The meeting provides an educational experi- ence and the opportunity to review thousands of scien- tific abstracts highlighting updates in the hottest topics in hematology. Network with top minds in the field, as well as a global community of more than 25,000 hematology professionals from every subspecialty. In addition to the educational sessions, the ASH exhibit halls feature the lat- est technology and research and a wide range of products and services offered by nearly 250 exhibitors. Exhibitors will include pharmaceutical companies, medical suppliers, clin- ical diagnostic and research- based companies, publishers, and nonprofit organizations. Precision Medicine World Congress (PMWC) Silicon Valley, CA, January 22–24 The Precision Medicine World Conference (PMWC) tra- verses a broad range of innovative technologies, initiatives, and clinical case studies that enable the translation of preci- sion medicine into direct improvements in patient care. Join more than 1,500 conference attendees to learn first-hand about the latest developments and advancements in preci- sion medicine and cutting-edge new strategies and solutions that are changing how patients are treated. PMWC features more than 70 educational sessions featuring more than 250 speakers including an opening Keynote presentation by Sir John Bell of Oxford University. The conference features four tracks which will showcase the latest advancements in pre- cision medicine on topics such as immuno-oncology, can- cer and rare disease diagnostics, AI and machine learning, CRISPR, the human microbiome, and others. One track will be dedicated to various aspects of the All of Us precision medicine research program of NIH. Molecular Medicine Tri-Conference San Francisco, February 11–16 Join more than 3,700 drug discovery and development professionals worldwide in San Francisco. Now in its 25th year, the International Molecular Medicine Tri-Conference (Molecular Tri-Con) attracts more than 3,700 drug discovery and development professionals from more than 40 coun- tries. Since its debut in 1993, the conference has become one of the world's leading international events in the field of drug discovery, development and diagnostics. Over the course of five days, this year 's meeting features six par- allel conference tracks, s Symposia, and 25 in-depth short courses. Compelling educational session include best prac- tice case studies and joint partner presentations, featuring more than 500 industry and academic experts in the areas of cancer research, big data, molecular diagnostics, precision medicine, rare diseases, data science, human microbiome, point-of-care diagnostics, infectious diseases, and more. Advances in Genome Biology and Technology (AGBT) Orlando, FL, February 12–15 Nearly 1,000 researchers from around the world will meet in Orlando, FL for Advances in Genome Biology and Technol- ogy (AGBT). As a recognized cornerstone for the genomics research community, AGBT provides a forum for exchang- ing information about the latest advances in DNA sequenc- ing technologies, experimental and analytical approaches for genomic studies, and their myriad applications. The meeting format includes daytime plenary sessions featuring invited speakers and abstract-selected talks that highlight cutting-edge research across the broad genomics landscape. Concurrent evening sessions includes experimental and computational approaches for effectively utilizing the latest DNA sequencing technologies.

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - NOV-DEC 2017